(Q37166318)

18 August 2017

1 reference

title

Neurologic and psychiatric manifestations of HIV disease (English)

1 reference

18 August 2017

Hollander H

1

1 reference

18 August 2017

publication date

1 January 1991

1 reference

Journal of General Internal Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

6

1 reference

18 August 2017

issue

1 Suppl

1 reference

18 August 2017

page(s)

S24-31

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02599254

18 August 2017

exact match

0 references

cites work

Subacute Encephalitis in Acquired Immune Deficiency Syndrome: A Postmortem Study

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

The AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Neuroradiologic findings in AIDS: a review of 200 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Cytomegalovirus Encephalitis in Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Cerebrospinal fluid normalities and abnormalities in individuals infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Primary human T-lymphotropic virus type III infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Syphilis and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599254

Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

12 December 2020

Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers

1 reference

12 December 2020

Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients

1 reference

12 December 2020

Polymyositis associated with AIDS retrovirus

1 reference

12 December 2020

Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.

1 reference

12 December 2020

Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.

1 reference

12 December 2020

Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.

1 reference

12 December 2020

Zidovudine-associated myopathy

1 reference

12 December 2020

Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment

1 reference

12 December 2020

Herpes simplex virus type 2 encephalitis in two homosexual men with persistent lymphadenopathy

1 reference

12 December 2020

HTLV-III infection in brains of children and adults with AIDS encephalopathy.

1 reference

12 December 2020

Neuropsychiatric manifestations of AIDS-spectrum disorders.

1 reference

12 December 2020

Neurosyphilis in the patient infected with human immunodeficiency virus

1 reference

12 December 2020

Neurologic manifestations of AIDS.

1 reference

12 December 2020

Neuropsychiatric complications of AIDS: a literature review

1 reference

12 December 2020

Treatment of toxoplasmic encephalitis with intravenous clindamycin

1 reference

12 December 2020

The AIDS dementia complex: I. Clinical features

1 reference

12 December 2020

New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases

1 reference

12 December 2020

Maintenance amphotericin B for cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1 reference

12 December 2020

Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy

1 reference

12 December 2020

Cytomegalovirus. Induced demyelination associated with acquired immune deficiency syndrome

1 reference

12 December 2020

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

12 December 2020

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

1 reference

12 December 2020

Extrapyramidal symptoms in AIDS patients given low-dose metoclopramide or chlorpromazine

1 reference

12 December 2020

Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome

1 reference

12 December 2020

Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy

1 reference

12 December 2020

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine

1 reference

12 December 2020

Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome

1 reference

12 December 2020

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature

1 reference

12 December 2020

Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Mitochondrial myopathy caused by long-term zidovudine therapy

1 reference

12 December 2020

The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study

1 reference

12 December 2020

Human immunodeficiency virus-associated myopathy: analysis of 11 patients

1 reference

12 December 2020

Cryptococcosis in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Human immunodeficiency virus-associated meningitis. Clinical course and correlations

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02599254

1 reference

18 August 2017

1 reference